TABLE 6.
MNP | S | MW | QPLogP o/w | QPlogS | QPLogK | QPPCaco | QPlogBB | PHOA | RO5 | JRO3 | The most similar drug (%) |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | 11 | 600.71 | −3.39 | 2.00 | −3.19 | 0 | −5.32 | 0 | 3 | 1 | Trientine (50) |
2 | 1 | 640.76 | 1.53 | −4.29 | −0.83 | 0 | −3.40 | 7 | 2 | 1 | Sulfamazone (65.2) |
3 | 11 | 818.97 | 2.00 | −5.16 | −0.84 | 0 | −4.83 | 0 | 3 | 2 | Dirithromycin (60.45) |
4 | 11 | 798.96 | 1.78 | −3.96 | −0.91 | 0 | −3.88 | 0 | 3 | 2 | Monoxerutin (64.25) |
5 | 1 | 638.74 | 1.00 | −3.17 | −1.01 | 0 | −3.00 | 6 | 2 | 1 | Sulfamazone (69.7) |
6 | 5 | 718.85 | 2.16 | −6.24 | −0.52 | 0 | −3.80 | 0 | 3 | 2 | Azithromycin (65.70) |
7 | 11 | 819.04 | 7.21 | −10.30 | 1.40 | 36 | −2.68 | 59 | 3 | 2 | Rifaximin (56.25) |
8 | 3 | 456.35 | −1.04 | −2.04 | −1.47 | 0 | −3.68 | 0 | 2 | 1 | Methotrexate (79.50) |
9 | 2 | 702.85 | 3.34 | −4.86 | −0.26 | 1 | −3.12 | 9 | 3 | 2 | Cefotiam (66) |
10 | 1 | 599.60 | 3.22 | −4.24 | −0.13 | 9 | −2.45 | 23 | 3 | 2 | Amprenavir (68.5) |
11 | 9 | 618.44 | −2.24 | −0.86 | −1.25 | 0 | −4.93 | 0 | 3 | 2 | Lymecycline (67.23) |
S (STARS) = Number of property/descriptor values falling outside the 95% range of similar values for known drugs. Recommended value 0–5. MW = Molecular weight Recommended values 130.0–725.0. QPlogPo/w = Predicted octanol/water partition coefficient. Recommended values –2.0–6.5. QPlogK = hsa Serum Protein Binding.Recommended values −1.5–1.5). QPlogS = Predicted aqueous solubility, log S. Recommended values –6.5–0.5. QPPCaco = Predicted apparent Caco-2 cell permeability in nm/sec. Recommended values < 25 poor, >500 great. QPlogBB = Predicted brain/blood partition coefficient. Recommended values –3.0–1.2. PHOA = Predicted human oral absorption on 0–100% scale. Recommended values > 80% is high <25% is poor. RO5 = Rule of Five, The rules are: mol_MW < 500, QPlogPo/w < 5, donorHB ≤5, and accptHB ≤10. Maximum is 4. JRO3 = Jorgensen Rule of 3 Violations. Maximum is 3.